Geir Melen
Vermögen: 85 794 $ am 31.08.2026
Vermögen: 85 794 $ am 31.08.2026
Geir Christian Melen is currently Director at Kaydence Pharma USA and Chief Financial Officer at Zelluna ASA. Former positions include Chief Executive Officer at Weifa ASA and Ostomycure AS, Director at Aqua Bio Technology ASA and Kaydence Pharma AS, Chief Financial Officer at Photocure ASA, Algeta ASA, and Tellus Petroleum AS.
Education includes a graduate degree from the Norwegian School of Economics & Business Administration.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,09 % | 31.12.2025 | 27.660 ( 0,09 % ) | 85 794 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Kaydence Pharma USA
Kaydence Pharma USA Pharmaceuticals: MajorHealth Technology Develops menaquinone-7 for the treatment of vascular and tissue calcification-related diseases | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| WEIFA ASA | Vorstandsvorsitzender | 01.02.2010 |
| ALGETA ASA | Finanzdirektor/CFO | - |
| PHOTOCURE ASA | Finanzdirektor/CFO | 01.01.2008 |
Kaydence Pharma AS
Kaydence Pharma AS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
Tellus Petroleum AS
Tellus Petroleum AS Oil & Gas ProductionEnergy Minerals Develops and produces oil and gas | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Aqua Bio Technology ASA
Aqua Bio Technology ASA Chemicals: Major DiversifiedProcess Industries Develops, produces and commercializes cosmetic ingredients for use in skin care products | Process Industries |
Photocure ASA
Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
Weifa ASA
Weifa ASA Pharmaceuticals: MajorHealth Technology Manufactures non-prescription and over-the-counter pharmaceutical products | Health Technology |
Norwegian School of Economics & Business Administration
Norwegian School of Economics & Business Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Ostomycure AS
Ostomycure AS Miscellaneous Commercial ServicesCommercial Services Develops solution for evacuating of fluids from the intestines | Commercial Services |
Tellus Petroleum AS
Tellus Petroleum AS Oil & Gas ProductionEnergy Minerals Develops and produces oil and gas | Energy Minerals |
Kaydence Pharma AS
Kaydence Pharma AS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kaydence Pharma USA
Kaydence Pharma USA Pharmaceuticals: MajorHealth Technology Develops menaquinone-7 for the treatment of vascular and tissue calcification-related diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen